Blood product transfusion practices in neonates with hypoxic-ischemic encephalopathy.
Journal
Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884
Informations de publication
Date de publication:
15 Aug 2024
15 Aug 2024
Historique:
received:
12
03
2024
accepted:
31
07
2024
revised:
24
07
2024
medline:
16
8
2024
pubmed:
16
8
2024
entrez:
15
8
2024
Statut:
aheadofprint
Résumé
Blood product transfusion is a common practice in infants with hypoxic-ischemic encephalopathy (HIE) undoing therapeutic hypothermia (TH). The advantages and disadvantages of conservative or liberal transfusion practices in this fragile population are unknown. Study aims to characterize the transfusion practices in infants with HIE and investigate the association with outcome. We conducted a retrospective cohort study at a single level IV NICU, evaluating transfusion thresholds, as well as the association between hematological abnormalities or blood product transfusions and outcomes in infants admitted with HIE. By univariate analysis, FFP transfusion was associated with increased in-hospital death. However, multivariate analysis adjusting for HIE severity demonstrated no association between hematological abnormality or blood product transfusion and death, nor with neurodevelopmental impairment. No association was found between hematological blood product transfusion and death or neurodevelopmental impairment in a retrospective single NICU study of infants with HIE.
Identifiants
pubmed: 39147790
doi: 10.1038/s41372-024-02092-1
pii: 10.1038/s41372-024-02092-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663–70. https://doi.org/10.1016/S0140-6736(05)17946-X .
doi: 10.1016/S0140-6736(05)17946-X
pubmed: 15721471
Pierrat V, Haouari N, Liska A, Thomas D, Subtil D, Truffert P, et al. Prevalence, causes and outcome at 2 years of age of newborn encephalopathy: population based study. Arch Dis Child Fetal Neonatal Ed. 2005;90:F357–261. https://doi.org/10.1136/adc.2003.047985 .
doi: 10.1136/adc.2003.047985
Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–84. https://doi.org/10.1056/NEJMcps050929 .
doi: 10.1056/NEJMcps050929
pubmed: 16221780
Azzopardi D, Brocklehurst P, Edwards D, Halliday H, Levene M, Thoresen M, et al. The TOBY study. Whole body hypothermia for the treatment of perinatal asphyxia encephalopathy: A randomised controlled trial. BMC Pediatr. 2008;8:17 https://doi.org/10.1186/1471-2431-8-17 .
doi: 10.1186/1471-2431-8-17
pubmed: 18447921
pmcid: 2409316
Azzopardi DV, Strohm B, Edwards D, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361:1349–58. https://doi.org/10.1056/NEJMoa0900854 .
doi: 10.1056/NEJMoa0900854
pubmed: 19797281
Gunn AJ, Thoresen M. Neonatal encephalopathy and hypoxic-ischemic encephalopathy. Handb Clin Neurol. 2019;162:217–37. https://doi.org/10.1016/B978-0-444-64029-1.00010-2 .
doi: 10.1016/B978-0-444-64029-1.00010-2
pubmed: 31324312
Robertson CM, Finer NN, Grace MG. School performance of survivors of neonatal encephalopathy associated with brain asphyxia at term. J Pediatr. 1989;114:753–60. https://doi.org/10.1016/s0022-3476(89)80132-5 .
doi: 10.1016/s0022-3476(89)80132-5
pubmed: 2469789
Odd DE, Gunnell D, Lewis G, Rasmussen F. Long term impact of poor birth condition on social and economic outcomes in early outcomes in early adulthood. Pediatrics. 2011;127:e1498–e1504. https://doi.org/10.1542/peds.2010-3604 .
doi: 10.1542/peds.2010-3604
pubmed: 21555491
Forman KR, Diab Y, Wong EC, Baumgart S, Luban NL, Massaro AN. Coagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia: a retrospective case-control study. BMC Pediatr. 2014;14:277 https://doi.org/10.1186/1471-2431-14-277 .
doi: 10.1186/1471-2431-14-277
pubmed: 25367591
pmcid: 4289197
Pakvasa MA, Winkler AM, Hamrick SE, Josephson CD, Patel RM. Observational study of haemostatic dysfunction and bleeding in neonates with hypoxic-ischaemic encephalopathy. BMJ Open. 2017;6:e013787 https://doi.org/10.1136/bmjopen-2016-013787 .
doi: 10.1136/bmjopen-2016-013787
Beltempo M, Wintermark P, Mohammad K, Jabbour E, Afifi J, Shivananda S, et al. Variations in practices and outcomes of neonates with hypoxic ischemic encephalopathy treated with therapeutic hypothermia across tertiary NICUs in Canada. J Perinatol. 2022;42:898–906. https://doi.org/10.1038/s41372-022-01412-7 .
doi: 10.1038/s41372-022-01412-7
pubmed: 35552529
Keir AK, McPhee AJ, Andersen CC, Stark MJ. Plasma cytokines and markers of endothelial activation increase after packed red blood cell transfusion in the preterm infant. Pediatr Res. 2013;73:75–79. https://doi.org/10.1038/pr.2012.144 .
doi: 10.1038/pr.2012.144
pubmed: 23095979
Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C, et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med. 2019;380:242–51. https://doi.org/10.1056/NEJMoa1807320 .
doi: 10.1056/NEJMoa1807320
pubmed: 30387697
Davenport P, Sola-Visner M. Platelet transfusions in neonates: beyond hemostasis. Arterioscler Thromb Vasc Biol. 2023;43:886–8. https://doi.org/10.1161/ATVBAHA.123.319252 .
doi: 10.1161/ATVBAHA.123.319252
pubmed: 37139838
pmcid: 10538175
Davenport P, Sola-Visner M. Immunologic effects of red blood cell and platelet transfusions in neonates. Curr Opin Hematol. 2022;29:297–305. https://doi.org/10.1097/MOH.0000000000000736 .
doi: 10.1097/MOH.0000000000000736
pubmed: 36165536
pmcid: 9547840
Davenport P, Sola-Visner M. Platelets in the neonate: not just a small adult. Res Pr Thromb Haemost. 2022;6:e12719 https://doi.org/10.1002/rth2.12719 .
doi: 10.1002/rth2.12719
Maouia A, Rebetz J, Kapur R, Semple JW. The immune nature of platelets revisited. Transfus Med Rev. 2020;34:209–20. https://doi.org/10.1016/j.tmrv.2020.09.005 .
doi: 10.1016/j.tmrv.2020.09.005
pubmed: 33051111
pmcid: 7501063
Anglin CO, Spence JS, Warner MA, Paliotta C, Harper C, Moore C, et al. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diathesis. J Neurosurg. 2013;118:676–86. https://doi.org/10.3171/2012.11.JNS12622 .
doi: 10.3171/2012.11.JNS12622
pubmed: 23259827
Patel RM, Knezevic A, Shenvi N, Hinkes M, Keene S, Roback JD, et al. Association of red blood cell transfusion, anemia and necrotizing enterocolitis in very low-birth-weight infants. JAMA. 2016;315:889–97. https://doi.org/10.1001/jama.2016.1204 .
doi: 10.1001/jama.2016.1204
pubmed: 26934258
pmcid: 4805423
Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149:301–7. https://doi.org/10.1016/j.jpeds.2006.05.011 .
doi: 10.1016/j.jpeds.2006.05.011
pubmed: 16939737
Williams MD, Chalmers EA, Gibson BES. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol. 2002;119:295–309. https://doi.org/10.1046/j.1365-2141.2002.03674.x .
doi: 10.1046/j.1365-2141.2002.03674.x
pubmed: 12406062
Gunnink SF, Vlug R, Fijnvandraat K, van der Bom JG, Stanworth SJ, Lopriore E. Neonatal thrombocytopenia: etiology, management and outcome. Expert Rev Hematol. 2014;7:387–95. https://doi.org/10.1586/17474086.2014.902301 .
doi: 10.1586/17474086.2014.902301
pubmed: 24665958
Hochart A, Pierache A, Jeanpierre E, Laffargue A, Susen S, Goudemand J. Coagulation standards in healthy newborns and infants. Arch de Pédiatrie. 2021;28:156–8. https://doi.org/10.1016/j.arcped.2020.10.007 .
doi: 10.1016/j.arcped.2020.10.007
Lau W Neonatal and Pediatric Transfusion. Canadian Blood Services Chapter 13 2017; 1-13.
Balasundaram P, Avulakunta ID Bayley Scales Of Infant and Toddler Development. [Updated 2022 Nov 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–23. https://doi.org/10.1111/j.1469-8749.1997.tb07414 .
doi: 10.1111/j.1469-8749.1997.tb07414
pubmed: 9183258
Moore CM, D’Amore A, Fustolo-Gunnink S, Hudson C, Newton A, Santamaria BL, et al. Two-year outcomes following a randomised platelet transfusion trial in preterm infants. Arch Dis Child Fetal Neonatal Ed 2023;108:452–7. https://doi.org/10.1136/archdischild-2022-324915 .
doi: 10.1136/archdischild-2022-324915
pubmed: 36810309
Davenport P, Fan HH, Nolton E, Feldman HA, Lorenz V, Canas J, et al. Platelet transfusions in a murine model of neonatal polymicrobial sepsis: Divergent effects on inflammation and mortality. Transfusion. 2022;62:1177–87. https://doi.org/10.1111/trf.1689 .
doi: 10.1111/trf.1689
pubmed: 35522536
Kirpalani H, Bell EF, Hintz SR, Tan S, Schmidt B, Chaudhary AS, et al. Higher or lower hemoglobin transfusion thresholds for preterm infants. N Engl J Med. 2020;383:2639–51. https://doi.org/10.1056/NEJMoa2020248 .
doi: 10.1056/NEJMoa2020248
pubmed: 33382931
pmcid: 8487591
Franz AR, Engel C, Bassler D, Rüdiger M, Thome UH, Maier RF, et al. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial. JAMA. 2020;324:560–70. https://doi.org/10.1001/jama.2020.10690 .
doi: 10.1001/jama.2020.10690
pubmed: 32780138